Verano Holdings (VRNO) Change in Account Payables (2021 - 2026)

Verano Holdings' (VRNO) quarterly Change in Account Payables came in at -$5.7 million in Q1 2026, down 175.52% year-on-year from $7.6 million in Q1 2025, and down 329.87% on a QoQ basis from -$1.3 million in Q4 2025.

Verano Holdings (VRNO) Change in Account Payables (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Change in Account Payables data on file, last reported at -$5.7 million in Q1 2026.

  • On a quarterly basis, Change in Account Payables fell 175.52% year-over-year to -$5.7 million in Q1 2026; TTM through Mar 2026 was -$7.9 million, a 206.61% decrease from a year earlier, with the FY2025 full-year figure at $5.4 million, up 228.5% from the prior year.
  • Change in Account Payables for Q1 2026 stood at -$5.7 million, down from -$1.3 million in the prior quarter.
  • Over the last five years, Change in Account Payables for VRNO reached as high as $19.9 million in Q1 2022 and fell as low as -$13.7 million in Q4 2022.
  • Historically, Change in Account Payables has averaged -$1.2 million across 5 years, with a median of -$3.0 million in 2024.
  • On a YoY basis, Change in Account Payables climbed as much as 2522.59% in 2024 and fell as far as 495.85% in 2024.
  • Year by year, Change in Account Payables stood at -$13.7 million in 2022, then soared by 96.32% to -$506000.0 in 2023, then tumbled by 495.85% to -$3.0 million in 2024, then surged by 55.92% to -$1.3 million in 2025, then slumped by 329.87% to -$5.7 million in 2026.
  • Per Business Quant data, the three most recent Change in Account Payables figures were -$5.7 million in Q1 2026, -$1.3 million in Q4 2025, and $5.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn -5.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.71 Mn
Mar 31, 2026 -5.71 Mn
Dec 31, 2025 -1.33 Mn
Dec 31, 2025 -1.33 Mn
Sep 30, 2025 5.35 Mn
Sep 30, 2025 5.35 Mn
Jun 30, 2025 -6.21 Mn
Jun 30, 2025 -6.21 Mn
Mar 31, 2025 7.57 Mn
Mar 31, 2025 7.57 Mn
Dec 31, 2024 -3.02 Mn
Dec 31, 2024 -3.02 Mn
Sep 30, 2024 8.71 Mn
Sep 30, 2024 8.71 Mn
Jun 30, 2024 -5.84 Mn
Jun 30, 2024 -5.84 Mn
Mar 31, 2024 -4.03 Mn
Mar 31, 2024 -4.03 Mn
Dec 31, 2023 -506,000.00
Dec 31, 2023 -506,000.00